Proteins Express Health

Health Outlook is using modern proteomics to better predict health events and improve health outcomes.

Laborary vial filled with blood

More than just a vial...

New technologies allow scientists to measure thousands of proteins from a vial of blood.

...powerful health insights

The Health Prediction Company

Our Mission

  • Make better predictions of health events than available options today.
  • We use advanced statistical and AI techniques to bridge the gap between today’s world of massive proteomic datasets and real-world practice.
  • Our long-term ambition is to apply such algorithms to support measures to shift the human life expectancy curve.

We leverage health prediction algorithms across healthcare ecosystem

Management

Our Leadership Team

headshot of Eddie Adams, Chief Product and Scientifc Officer

Eddie Adams, PhD

Chief Product & Scientific Officer

Leads scientific innovation and product development at Health Outlook. Extensive experience in liquid biopsy diagnostics, epigenetics, and molecular diagnostics. Previously led R&D efforts at Micronoma, Active Motif, and MO BIO Laboratories (acquired by Qiagen). Former Director of Molecular Diagnostics at NanoMR. Inventor on numerous patents in diagnostics, epigenetics, sample preparation, and nanotechnology. Holds a BS in Biotechnology from Rochester Institute of Technology and a PhD in Biological Chemistry from MIT.

headshot of Nicola Jessen, Head of Marketing

Nicola Jessen

Head of Marketing

Drives Health Outlook’s go-to-market, leveraging deep expertise in digital transformation, customer collaboration, and growth initiatives. Previously led digitalization and automation efforts at Siemens Healthineers across Central Eastern Europe and Central Asia. Held multiple global roles in strategy, M&A, digital transformation, and product development. Extensive experience as Head of Marketing at startups, focusing on market expansion and innovation. MS in Informatics and Information Systems from the University of Augsburg.

headshot of John Marques, Director of Origination, Velocity Life

John Marques

Director of Origination, Velocity Life

Brings a diverse background across entertainment, jewelry, and life sciences. Currently leads origination at Velocity Life Settlements, with prior experience as Vice President at FairMarket Life Settlements and multiple Fund Manager roles. Expertise in life settlements with a bachelor’s degree from DePaul University.

headshot of Adam Brzozowski, Head of Data Insights and Analytics

Adam Brzozowski

Head of Data Insights & Analytics

Leads advanced data science applications for disease modeling. Previously Vice President of Data Insights & Analytics at Modivcare. Holds an ALM in Data Science from Harvard University, an MBA from Quinnipiac University, and triple BA degrees in Mathematical Economics, History, and Political Science from Eastern Connecticut State University.

headshot of Sharon Reese, Head of Accounting

Sharon Reese

Head of Accounting

Oversees Health Outlook’s accounting and financial operations, ensuring compliance, reporting accuracy, and strategic financial management. CFO Partner at TechCXO with a strong track record in life sciences. Previously served as Chief Financial Officer and Vice President of Finance & Compliance at AgNovos Bioscience, BioReliance, and United BioSource Corporation. Holds a BS in Accounting from Penn State University and is a Certified Public Accountant.

headshot of Joe El-Khoury, Lab Director

Joe El-Khoury, PhD, DABCC

Assoc. Professor & Lab Director

Leads clinical research and laboratory operations focused on advancing biomarker discovery and diagnostics. He is also the Director of the Clinical Chemistry Laboratory at Yale New Haven Health and an Associate Professor of Laboratory Medicine at Yale School of Medicine. Board-certified by the American Board of Clinical Chemistry and a fellow of the ADLM Academy. Extensive experience in clinical diagnostics, kidney disease biomarkers, and mass spectrometry applications.

headshot of John Turcotte, Lab Manager

John Turcotte

Lab Manager

As Chemistry Technical Supervisor and Quality Assurance Officer, leads day-to-day laboratory operations. Previously Laboratory Supervisor – Chemistry at Griffin Hospital and Laboratory Supervisor at Cornell Scott – Hill Health Center, overseeing diagnostic testing, assay validation, equipment maintenance, and compliance with accreditation standards. Brings extensive experience in clinical laboratory management, process optimization, and personnel training.

headshot of Eric Faulkner, Chief Information Officer

Eric Faulkner

Chief Information Officer

Oversees IT strategy and digital transformation. Extensive experience in scaling software, M&A integration, and product development. Held senior leadership roles at Corcentric, Determine, 10Pearls, and Federated Sports & Gaming. MS in Information Technology from Virginia Tech.

Board of Directors

headshot of Tim Opler, PhD, Co-Founder and Board Member

Tim Opler, PhD

Chairman & Co-Founder,
Health Outlook

Managing Director at Stifel’s Global Healthcare Group. Co-founded Torreya, later acquired by Stifel. Nearly 20 years of experience in life sciences advisory, completing over 150 strategic and financing transactions. Former Vice President of Strategy at FibroGen and healthcare investment banker at Credit Suisse First Boston. PhD in Economics from UCLA.

headshot of Tadd Wessel, Board Member

Tadd Wessel

Founder & Managing Partner, Petrichor

Founder and Managing Partner of Petrichor, a healthcare-focused investment firm, and Scion Life Sciences, a Petrichor affiliate. Over 25 years of experience in life sciences investing, previously Partner at OrbiMed Advisors. Serves on multiple boards, including ITM and Aurion Biotech. Holds an AB in Biology from Princeton University.

headshot of Hayden Fownes, Board Member

Hayden Fownes

Vice President,
Petrichor

Joined Petrichor at launch, focuses on investment sourcing, execution, and portfolio management. Prior to Petrichor, Hayden worked in the Global Healthcare Investment Banking group at Bank of America, where he executed financings and M&A for clients across all life sciences subsectors. BS in Finance from Wake Forest University.

headshot of Adam Morgan, Board Member

Adam Morgan

Partner, Avego &
CIO, Velan Capital

Nearly two decades of experience in healthcare investing and asset management. Former Senior Analyst at Broadfin Capital and Iguana Healthcare. Background in medical devices with leadership roles across engineering, sales, and strategy. BS in Chemistry and MBA from the University of Minnesota.

Advisory Board

headshot of Andy Dannenberg, Advisory Board Member

Andy Dannenberg, MD

Former Professor Medicine,
Weill Cornell Medical College

Partner at Emerald Bioventures. Formerly was Professor of Medicine at Weill Cornell Medical College. Author of 200+ scientific publications. Expert on inflammation and cancer. MD Wash U., St. Louis.

headshot of Paul Ridker, Advisory Board Member

Paul Ridker, MD

Professor of Medicine,
Harvard University

Dr. Ridker is a cardiovascular epidemiologist and biomedical researcher whose research has provided proof-of-principle for the inflammation hypothesis of atherosclerosis and the first proven anti-inflammatory treatment for coronary artery disease.

headshot of Richard Ulevitch, Advisory Board Member

Richard Ulevitch, PhD

Dept. Immunology,
Scripps Research Institute

Richard Ulevitch is professor of immunology and Chairman Emeritus of the Department of Immunology at The Scripps Research Institute. His career is marked by a number of seminal scientific discoveries in the field of innate immunity. He has a strong ongoing interest in implications of proteomics for science and medicine. He received a PhD in Immunology from the University of Pennsylvania.

headshot of David Shulkin, Advisory Board Member

David Shulkin, MD

Former Secretary,
Veterans Administration

Dr. Shulkin is an American physician and former U.S. Secretary of Veterans Affairs. Shulkin was also CEO of Beth Israel Medical Center and was president of Morristown Medical Center. He was the first CMO of the University of Pennsylvania Hospital.

headshot of Mark Simon, Advisory Board Member

Mark Simon

Co-Founder and Advisor, Torreya

Mark Simon is a partner at Torreya Partners, which he co-founded in 2007. He brings over 20 years of experience in advising biotech companies. He is active on numerous boards including that for the Alliance for Aging Research. Before Torreya, Simon was in investment banking at Citigroup and Robertson Stephens. Mark received an MBA from Harvard Business School.

headshot of Ravi J. Patel, Advisory Board Member

Ravi J. Patel, DO

Board Certified Emergency Medicine

Ravi Patel is a Board Certified Emergency Physician. He completed his medical school at the West Virginia School of Osteopathic Medicine and completed his residency at the University of Missouri-Kansas City where he served as chief resident. Dr. Patel has become passionate about digital health and using health informatics to solve complex logistical and analytical problems.

headshot of Dan Lewis, Advisory Board Member

Dan Lewis

Board Member, Lobesity

Accomplished C-suite executive across multiple industries. Recently, worked in healthcare as the COO of a $1.5B hospital system and in biotech as the CEO of Lobesity, a start-up company dedicated to the treatment of obesity. Successfully led the exit in 2021 and remains a Board Member. Currently, advises other start-ups in the health tech sector. Received a BA degree from Kent State University and an MA from the University of Akron.

The Health
Prediction Company

Get in touch